FRA:BAYN - Bayer Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
€92.05 -0.30 (-0.32 %)
(As of 07/20/2018 04:00 PM ET)
Previous Close€92.05
Today's Range€91.48 - €93.35
52-Week Range€91.58 - €123.82
Volume4.63 million shs
Average VolumeN/A
Market Capitalization$78.80 billion
P/E RatioN/A
Dividend Yield2.93%
BetaN/A
Bayer logoBayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, and cosmetics in the dermatology, nutritional supplement, analgesic, digestive health, allergy, cold, foot care, and sun protection categories. The Crop Science segment offers crop protection products, seeds, non-agriculture pest control products. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to vets, farmers, and pet-owners. The company was founded in 1863 and is headquartered in Leverkusen, Germany.

Receive BAYN News and Ratings via Email

Sign-up to receive the latest news and ratings for BAYN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange FRA
Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
SymbolFRA:BAYN
CUSIPN/A
Phone+49-214-301

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares826,950,000
Market Cap$78,800.00

Bayer (FRA:BAYN) Frequently Asked Questions

What is Bayer's stock symbol?

Bayer trades on the FRA under the ticker symbol "BAYN."

What price target have analysts set for BAYN?

21 analysts have issued 12 month target prices for Bayer's stock. Their forecasts range from €98.00 to €140.00. On average, they expect Bayer's stock price to reach €118.45 in the next twelve months. This suggests a possible upside of 28.7% from the stock's current price. View Analyst Ratings for Bayer.

What is the consensus analysts' recommendation for Bayer?

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bayer in the last year. There are currently 7 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Bayer's key competitors?

Who are Bayer's key executives?

Bayer's management team includes the folowing people:
  • Mr. Werner Baumann, Chairman of Management & CEO (Age 56)
  • Mr. Johannes M. Dietsch, Head of Fin. Dept, CFO - Asia/Pacific Region & Member of Management Board (Age 56)
  • Mr. Liam Condon, CEO & Pres of Bayer Cropscience and Member of Management Board (Age 50)
  • Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 56)
  • Dr. Hartmut Klusik, Head of HR, Technology & Sustainability, Labor Director and Member of Management Board (Age 62)

Has Bayer been receiving favorable news coverage?

Media headlines about BAYN stock have trended positive this week, Accern Sentiment reports. Accern ranks the sentiment of press coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Bayer earned a news impact score of 0.26 on Accern's scale. They also gave news coverage about the healthcare company an impact score of 44.75 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

What is Bayer's stock price today?

One share of BAYN stock can currently be purchased for approximately €92.05.

How big of a company is Bayer?

Bayer has a market capitalization of $78.80 billion.

How can I contact Bayer?

Bayer's mailing address is Kaiser-Wilhelm-Allee 1, LEVERKUSEN, 51373, Germany. The healthcare company can be reached via phone at +49-214-301.


MarketBeat Community Rating for Bayer (FRA BAYN)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  1,095 (Vote Outperform)
Underperform Votes:  779 (Vote Underperform)
Total Votes:  1,874
MarketBeat's community ratings are surveys of what our community members think about Bayer and other stocks. Vote "Outperform" if you believe BAYN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAYN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/21/2018 by MarketBeat.com Staff

Featured Article: Earnings Per Share

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.